Skip to main content
GE, DARPA partner for development of type 2 diabetes treatment device

The Defense Advanced Research Projects Agency and General Electric are collaborating on a $2.9 million research project to develop bioelectronic devices for type 2 diabetes treatment. "Our project with DARPA aims to find a better alternative that treats diabetes with non-invasive medical devices without the side effects associated with drug treatments," said Victoria Cotero, a global research biologist at GE.

Full Story: